about
Models for institutional and professional accreditation of haemophilia centres in Italy.Anti-factor IXa/X bispecific antibody ACE910 prevents joint bleeds in a long-term primate model of acquired hemophilia A.Treatment for life for severe haemophilia A- A cost-utility model for prophylaxis vs. on-demand treatment.
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 20 June 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Pharmacotherapy of haemophilia A.
@en
Pharmacotherapy of haemophilia A.
@nl
type
label
Pharmacotherapy of haemophilia A.
@en
Pharmacotherapy of haemophilia A.
@nl
prefLabel
Pharmacotherapy of haemophilia A.
@en
Pharmacotherapy of haemophilia A.
@nl
P2093
P2860
P921
P1476
Pharmacotherapy of haemophilia A.
@en
P2093
Alessandro Gringeri
Lucia Mangiafico
Myrvet Muça-Perja
Sylvia von Mackensen
P2860
P304
P356
10.1517/14712598.2011.570006
P407
P577
2011-06-20T00:00:00Z